Novartis anti-leukemia drug works for 5 years, study says
(Reuters)
|
|
Wednesday, 06 December 2006 |
|
Reuters - Swiss drugmaker Novartis AG's
cancer-fighting drug Gleevec can still help treat chronic
myeloid leukemia even after five years of use, a new study
showed on Wednesday. |
